SCHEMBL532439

SCHEMBL532439

O=C1COc2ccc(C(=O)CN3CCOCC3)cc2N1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.64
MAPT P10636 6/20 0.64
GAA P10253 3/20 0.54
MAPK1 P28482 1/20 0.54
HTR1D P28221 2/20 0.53
RXFP1 Q9HBX9 1/20 0.53
NR3C2 P08235 1/20 0.53
HTR1A P08908 1/20 0.52
HTR1B P28222 1/20 0.52
PKM P14618 2/20 0.52
HSD17B10 Q99714 1/20 0.52
KDM4E B2RXH2 1/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
POLB P06746 1/20 0.50
TP53 P04637 1/20 0.50
ALDH3A1 P30838 1/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12125324 0.89 ALDH1A1 (0.65) ALDH1A1MAPTGAAMAPK1RXFP1
SCHEMBL5774571 0.86 ALDH1A1 (0.61) ALDH1A1MAPTGAAHTR1DRXFP1
SCHEMBL5659998 0.84 ALDH1A1 (0.59) ALDH1A1MAPTGAAHTR1DRXFP1
SCHEMBL2121267 0.82 PARP1 (0.67) ALDH1A1MAPTGAAHTR1DRXFP1
SCHEMBL532530 0.82 PARP1 (0.68) ALDH1A1MAPTGAAHTR1DRXFP1
SCHEMBL532062 0.81 NR3C2 (0.61) ALDH1A1MAPTGAAMAPK1NR3C2
SCHEMBL14346107 0.79 ALDH1A1 (0.64) ALDH1A1MAPTGAARXFP1NR3C2
SCHEMBL4264178 0.78 ALDH1A1 (0.75) ALDH1A1MAPTGAARXFP1PKM
SCHEMBL4291442 0.78 ALDH1A1 (0.75) ALDH1A1MAPTGAARXFP1PKM
SCHEMBL10652999 0.78 MAPT (0.78) ALDH1A1MAPTGAARXFP1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669249-B2 Poly (ADP-ribose) polymerase (PARP) inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-03-11 US disclosed
US-8669249-B2 Poly (ADP-ribose) polymerase (PARP) inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-03-11 US disclosed
US-8669249-B2 Poly (ADP-ribose) polymerase (PARP) inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-03-11 US disclosed
US-20120094992-A1 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-19 US disclosed
US-20120094992-A1 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-19 US disclosed
US-20120094992-A1 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-19 US disclosed
EP-2415767-A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors Takeda Pharmaceutical Company Limited (JP) 2012-02-08 EP disclosed
WO-2010111626-A2 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094992-A1 POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS PARP1, PARP2, PARP3 ALDH1A1 445/4885MAPT 2713/4885GAA 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.